NeuroMetrix, Inc.
- Jurisdiction
United States - LEI
549300WDIIBGIRV0N856 - ISIN
US6412558800 (NURO )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
2
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Read full profile
Stock price
Fundamentals
- Net revenue
€2.60M - Gross margin
55.4% - EBIT
-€7.53M - EBIT margin
-289.6% - Net income
-€6.70M - Net margin
-257.4%
Statement period: - (published )
Dividends
- Last dividend amount
-
$0.15 - Ex date
-
- Payment date
-
Earnings Calls
Latest earnings call: February 22, 2024
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |